TY  - GEN
AU  - Yokota,Tomoya
AU  - Hatooka,Shunzo
AU  - Ura,Takashi
AU  - Abe,Tetsuya
AU  - Takahari,Daisuke
AU  - Shitara,Kohei
AU  - Nomura,Motoo
AU  - Kondo,Chihiro
AU  - Mizota,Ayako
AU  - Yatabe,Yasushi
AU  - Shinoda,Masayuki
AU  - Muro,Kei
TI  - Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer
SN  - 1791-7530
PY  - 2011///1122
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Esophageal Neoplasms
KW  - drug therapy
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Postoperative Complications
KW  - etiology
KW  - Recurrence
KW  - Retrospective Studies
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
ER  -